1.65000 USD
0.02
1.23%
Last update Apr 1, 3:59 PM EDT
Market closed
Day range
1.62000
1.65000
Previous close
1.63000
Open
1.63000
Access this stock data via API
Subscribe
Aptose Biosciences Inc.
1.65
0.02
1.23%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 15.1M 36.8M 28.1M 46.0M
Selling general and admin 11.1M 15.5M 14.4M 19.3M
Other operating expenses
Operating income -26.3M -52.4M -42.6M -65.4M
Non operating interest income
Income 357K 1.2M 788K 94K
Expense 207K
Other income expense 677K -2K -9K -1K
Pretax income -25.4M -51.2M -41.8M -65.4M
Tax provision
Net income -25.4M -51.2M -41.8M -65.4M
Basic EPS -36.4 -7.6 -6.8 -11.0
Diluted EPS -36.4 -7.6 -6.8 -11.0
Basic average shares 699.0K 6.8M 6.2M 5.9M
Diluted average shares 699.0K 6.8M 6.2M 5.9M
EBITDA -25.5M -51.9M -42.1M -64.8M
Net income from continuing op. -25.4M -51.2M -41.8M -65.4M
Minority interests
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 1 hour 35 minutes

02:24
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EST, UTC-05:00).